Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1983-03-01

Evaluation of mutagenic effect of the fungicide fenaminosulf in Drosophila melanogaster.

S B Pai

Index: Mutat. Res. 119(3) , 289-91, (1983)

Full Text: HTML

Abstract

Fenaminosulf (p-dimethylaminobenzenediazo sodium sulfonate, CAS registry No. 140-56-7) which is an active ingredient in several commercial fungicides was reported to be mutagenic in Salmonella typhimurium (McCann et al., 1975), Bacillus subtilis (Kada et al., 1974) and shown to cause chromosome aberrations in plants (Zutshi and Kaul, 1975). Since fenaminosulf has structural similarity to the potent carcinogen, butter yellow (p-dimethylaminoazobenzene, CAS registry No. 60-11-7), the present studies were undertaken to evaluate the mutagenic potential of this fungicide in Drosophila melanogaster. Fenaminosulf administered at 10 mg/100 ml food medium failed to induce sex-linked recessive mutations in Drosophila. Since Drosophila has drug-metabolizing enzymes similar to those of mammals (Vogel, 1975), it is suggested that the lack of mutagenic activity of fenaminosulf could be due to the conversion of fenaminosulf to non-mutagenic derivatives in Drosophila.


Related Compounds

  • Fenaminosulf

Related Articles:

CYP2C9 genotype vs. metabolic phenotype for individual drug dosing--a correlation analysis using flurbiprofen as probe drug.

2015-01-01

[PLoS ONE 10(3) , e0120403, (2015)]

Experimental evaluation of a new composite mesh with the selective property of incorporation to the abdominal wall without adhering to the intestines.

1994-03-01

[J. Biomed. Mater. Res. 28(3) , 373-5, (1994)]

Safety evaluation of a triazine compound nitromezuril by assessing bacterial reverse mutation, sperm abnormalities, micronucleus and chromosomal aberration.

2015-04-01

[Regul Toxicol Pharmacol 71(3) , 585-9, (2015)]

The use of Dexon as a replacement for the calcaneal tendon in sheep.

1985-03-01

[J. Bone Joint Surg. Br. 67(2) , 313-6, (1985)]

Intestinal complications associated with use of the Dexon mesh sling in gynecologic oncology patients.

1990-07-01

[Gynecol. Oncol. 38(1) , 146-8, (1990)]

More Articles...